However, clinical trials have shown semaglutide to be effective in aiding weight loss in patients with obesity
Kim H, et al
The UK is currently experiencing supply constraints for some GLP-1 receptor agonists, and NHS England advises against off-label prescribing of diabetes products for weight management alone
Keeping the pharmacy reachable matters most if a trip runs longer than planned
5 NHS eligibility for Mounjaro (obesity) BMI of 40 or above, or 37.5 or above for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds At least 4 of the following 5 qualifying conditions: type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or established cardiovascular disease Engagement with a behavioural support programme alongside the medication Minimum 5% weight loss at 6 months to continue treatment CKD isnt one of the qualifying conditions for NHS access, but many people with CKD also have type 2 diabetes, hypertension, or dyslipidaemia, which may make them eligible through those pathways
The effects of intrapersonal anger and its regulation in economic bargaining
